Activities per year
Results: To study the impact of Abhd15 on lipolysis in vitro, we generated 3T3-L1 cells stably overexpressing Abhd15 (Abhd15 o/e) and differentiated them into adipocytes. Our results show that Abhd15 o/e strongly increased basal glycerol release and phosphorylation of HSL at Ser660 in adipocytes. In Cos7 cells, we confirmed the interaction of Abhd15 with PDE3B and we could further show it in adipocytes. Additionally, increasing protein expression of Abhd15 reduced PDE3B protein expression in Cos7 cells and adipocytes. Concomitantly, PDE3B activity was inhibited by membrane fraction lysates from Abhd15 o/e Cos7 cells. We also investigated Abhd15 protein expression at different nutritional states in WAT. While fasting decreased Abhd15 expression, refeeding strongly increased it. PDE3B has the same expression pattern as Abhd15. Also, in WAT of Abhd15-ko mice, PDE3B mRNA and protein expression are strongly reduced in fasted and refed. Accordingly, our in vivo results show that Abhd15-ko mice do not shut down lipolysis after insulin injection.
Conclusion: Our data show that Abhd15 impacts PDE3B expression and activity, thereby affecting lipolysis in vitro and in vivo. In summary, we present Abhd15 as a novel regulator of PDE3B and suggest that Abhd15 plays an important role in insulin signaling, such as lipolysis and adaption to nutritional changes.
|Publication status||Published - 12 Sep 2016|
|Event||Lipoprotein Metabolism 2016 Gordon Research Conference - Waterville Valley in Waterville Valley NH United States, New Hampshire, United States|
Duration: 12 Jun 2016 → 17 Jun 2016
|Conference||Lipoprotein Metabolism 2016 Gordon Research Conference|
|Period||12/06/16 → 17/06/16|
Wenmin XIA (Participant)12 Jun 2016 → 17 Jun 2016
Activity: Participation in or organisation of › Conference or symposium (Participation in/Organisation of)